NCT04101682 is a EARLY_PHASE1 clinical trial of Bupivacaine in ACL Injury, sponsored by Northwell Health.

Who is sponsoring NCT04101682?

NCT04101682 is sponsored by Northwell Health.

What drugs are being tested in NCT04101682?

Interventions in NCT04101682: Bupivacaine.

What condition does NCT04101682 study?

NCT04101682 studies ACL Injury.

Is NCT04101682 still recruiting?

NCT04101682 is currently terminated. Last updated 18 October 2023.

Last reviewed 2023-10-18 · How we verify

NCT04101682

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Continuous Vs Single Shot Block After ACL

Terminated EARLY_PHASE1 Last updated 18 October 2023

What this trial tests

EARLY_PHASE1 trial testing Bupivacaine in ACL Injury in 9 participants. Terminated before completion.

Timeline

25 September 2020

Primary endpoint
17 May 2022

17 May 2022

Quick facts

Lead sponsor	Northwell Health
Phase	EARLY_PHASE1
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	9
Start date	25 September 2020
Primary completion	17 May 2022
Estimated completion	17 May 2022
Sites	1 location across United States

Drugs / interventions tested

Bupivacaine (BUPIVACAINE) — full drug profile →

Conditions studied

ACL Injury — all drugs for ACL Injury →

Sponsor

Northwell Health — full company profile →

Who can join

16 and older, any sex, with ACL Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators will be randomizing patients to either receive an adductor canal block in the operating room postoperatively as single shot of 20-30cc bupivacaine or to have a catheter inserted into the adductor canal which will be attached up to a continuous infusion pump of bupivacaine that will have a set flow rate over the next couple days. The investigators' hypothesis is that patients will have better pain control, sleep, and decreased opioid consumption with the use of a continuous infusion pump

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Bupivacaine

Trials testing the same drug.

NCT05785377 — Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
NCT07467356 — Anterior Iliopsoas Space Block Versus PENG Block on Ease of Positioning for Spinal Anathesia in Patients Undergoing Hip · Phase 3 · recruiting
NCT07465185 — Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery · Phase 2 · recruiting
NCT07430085 — Post-Operative Pain Relief: Zynrelef or Periarticular Injections in RATKA · Phase 4 · not yet recruiting
NCT07146685 — Effect of Local Anesthetic Concentration on Rebound Pain: A Randomized Control Study · Phase 4 · not yet recruiting

Other recruiting trials for ACL Injury

Currently open trials in the same condition.

NCT06529679 — Michigan Split-belt Treadmill Training Program to Improve Acute Knee Biomechanics After ACL Reconstruction · NA · recruiting
NCT06442319 — The Efficiency and Safety of PRP Treatment After Anterior Cruciate Ligament Reconstruction. · NA · recruiting
NCT06524869 — Association Between Neuromuscular Parameters and Functional Assessment After ACL Reconstruction · recruiting
NCT07387939 — ACL Reconstruction in Patients Aged 50 Years and Older · active not recruiting
NCT06194682 — Anterior Cruciate Ligament Study · recruiting

Other Northwell Health trials

Trials by the same sponsor.

NCT07253662 — Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients With Peritoneal Metastasis From Pancreatic Aden · Phase 1 · recruiting
NCT07191041 — Emotional Urinary Tract Infection · not yet recruiting
NCT07254091 — Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer · EARLY_PHASE1 · recruiting
NCT07344961 — Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB) · recruiting
NCT07193862 — Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Meta · EARLY_PHASE1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04101682 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Northwell Health
Last refreshed: 18 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04101682.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing